SCHEMBL22304529

SCHEMBL22304529

Cc1c(C#N)cccc1-c1cc(Cl)nc(N(C(=O)OC(C)(C)C)C(=O)OC(C)(C)C)n1

nearest known ligand 0.38

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 17/20 0.38
ADORA2B P29275 1/20 0.35
ADORA1 P30542 1/20 0.35
NISCH Q9Y2I1 1/20 0.34
HSP90AA1 P07900 1/20 0.34
HSP90AB1 P08238 1/20 0.34
NSD2 O96028 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30080281 1.00 ADORA2A (0.38) ADORA2AADORA2BADORA1NISCHHSP90AA1
SCHEMBL22304359 0.86 ADORA2A (0.36) ADORA2AADORA2BADORA1NISCH
SCHEMBL30080613 0.84 NISCH (0.39) ADORA2AADORA2BADORA1NISCH
SCHEMBL28569440 0.82 ADORA2A (0.34) ADORA2AADORA2BADORA1NISCH
SCHEMBL24326460 0.82 HSP90AA1 (0.40) HSP90AA1HSP90AB1
SCHEMBL22502015 0.78 HSP90AA1 (0.41) HSP90AA1HSP90AB1
SCHEMBL29566720 0.77 HSP90AA1 (0.36) HSP90AA1HSP90AB1
SCHEMBL24309477 0.77 HSP90AA1 (0.36) HSP90AA1HSP90AB1
SCHEMBL22304360 0.76 ADORA2A (0.59) ADORA2AADORA2BADORA1
SCHEMBL31108299 0.76 ADORA2A (0.59) ADORA2AADORA2BADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112996783-B 2-aminopyrimidine derivatives, preparation method and application thereof in medicines 江苏恒瑞医药股份有限公司 2022-11-18 CN disclosed
CN-112996783-A 2-aminopyrimidine derivatives, preparation method and application thereof in medicines 江苏恒瑞医药股份有限公司 2021-06-18 CN disclosed
WO-2020156505-A1 2-AMIONPYRIMIDINE DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN MEDICINES 江苏恒瑞医药股份有限公司 2020-08-06 WO disclosed